Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Panel stacking is a threat to consensus statement validityIn: Journal of Clinical Epidemiology , Jg. 173 2024, 111428
-
Persistent low-level viraemia is associated with non-infectious comorbidities in an observational cohort in four African countriesIn: Journal of the International AIDS Society , Jg. 27 2024, Nr. 8, e26316DOI (Open Access)
-
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading eventIn: Scientific Reports , Jg. 13 2023, Nr. 1, S. 5440DOI (Open Access)
-
Dynamics and durability of HIV-1 neutralization are determined by viral replicationIn: Nature Medicine , Jg. 29 2023, Nr. 11, S. 2763 – 2774DOI (Open Access)
-
Evaluation der Einführung der HIV-Präexpositionsprophylaxe als Leistung der gesetzlichen Krankenversicherung (EvE‑PrEP) : Hocheffektiver Schutz vor HIV und keine Zunahme von sexuell übertragbaren InfektionenIn: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz , Jg. 66 2023, Nr. 9, S. 1008 – 1018DOI (Open Access)
-
HIV-Associated Microbial Translocation May Affect Cytokine Production of CD56brⁱght NK Cells via Stimulation of MonocytesIn: The Journal of Infectious Diseases (JID) , Jg. 227 2023, Nr. 4, S. 577 – 582
-
High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in GermanyIn: Human Vaccines & Immunotherapeutics , Jg. 19 2023, Nr. 2, 2238576DOI (Open Access)
-
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patientsIn: Nature Communications , Jg. 14 2023, Nr. 1, 2835DOI (Open Access)
-
Preparing for future European efficacy trials of interventions to prevent HIV and other sexually transmitted infections : Lessons on willingness to participate and barriers to participation from ten German clinics serving behaviorally vulnerable men who have sex with menIn: Vaccine: X , Jg. 14 2023, 100302DOI (Open Access)
-
Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory VirusesIn: JACS Au , Jg. 2 2022, Nr. 9, S. 2187 – 2202DOI (Open Access)
-
Dissecting drivers of immune activation in chronic HIV-1 infectionIn: eBioMedicine , Jg. 83 2022, 104182DOI (Open Access)
-
Dynamics, outcomes and prerequisites of the first SARS-CoV-2 superspreading event in Germany in February 2020 : a cross-sectional epidemiological studyIn: BMJ Open , Jg. 12 2022, Nr. 4, e059809DOI (Open Access)
-
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019In: Eurosurveillance , Jg. 27 2022, Nr. 14, 2100591DOI (Open Access)
-
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19In: Nature , Jg. 609 2022, Nr. 7928, S. 801 – 807DOI (Open Access)
-
Reconstruction of the origin of the first major SARS-CoV-2 outbreak in GermanyIn: Computational and Structural Biotechnology Journal , Jg. 20 2022, S. 2292 – 2296DOI (Open Access)
-
Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase InhibitorsIn: Journal of Virology , Jg. 96 2022, Nr. 5, e01730-21DOI (Open Access)
-
Serological Markers of SARS-CoV-2 ReinfectionIn: mBio , Jg. 13 2022, Nr. 1, e02141 - 21DOI (Open Access)
-
A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent TuberculosisIn: Frontiers in Immunology , Jg. 12 2021, 729186DOI (Open Access)
-
Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany : A cross-sectional analysis upon enrollment into an observational cohortIn: AIDS Research and Therapy , Jg. 18 2021, Nr. 1, 52DOI (Open Access)
-
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsIn: Nature Communications , Jg. 12 2021, Nr. 1, S. 1112DOI (Open Access)
-
Production of HIV-1 env-specific antibodies mediating innate immune functions depends on cognate interleukin-21-secreting CD4⁺T cellsIn: Journal of Virology , Jg. 95 2021, Nr. 8, S. e02097DOI (Open Access)
-
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsIn: PLoS Pathogens , Jg. 17 2021, Nr. 11, e1010016DOI (Open Access)
-
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathologyIn: PLoS Pathogens , Jg. 16 2020, Nr. 3, e1008340DOI (Open Access)
-
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityIn: Cell , Jg. 183 2020, Nr. 6, S. 1508 – 1519.e12DOI (Open Access)
-
Evolution of Early SARS-CoV-2 and Cross-Coronavirus ImmunityIn: mSphere , Jg. 5 2020, Nr. 5, e006020 - 22DOI (Open Access)
-
IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccineesIn: JCI Insight , Jg. 5 2020, Nr. 21, e140925DOI (Open Access)
-
Mining for humoral correlates of HIV control and latent reservoir sizeIn: PLoS Pathogens , Jg. 16 2020, Nr. 10, e1008868DOI (Open Access)
-
Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune responseIn: JCI Insight , Jg. 5 2020, Nr. 12, e135057DOI (Open Access)
-
Rapid uptake of pre-exposure prophylaxis (PrEP) after significant price reduction in Germany highlights importance of PrEP accessibilityIn: AIDS Research and Human Retroviruses 2020
-
Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological ProcessesIn: Cells , Jg. 9 2020, Nr. 4, 1003DOI (Open Access)
-
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activationIn: Journal of Immunological Methods , Jg. 473 2019, S. 112630DOI (Open Access)
-
B-type natriuretic peptides for the prediction of cardiovascular events and mortality in patients living with HIV : Results from the HIV-HEART studyIn: International Journal of Cardiology , Jg. 281 2019, S. 127 – 132
-
Effect of HIV infection and antiretroviral therapy on immune cellular functionsIn: JCI Insight , Jg. 4 2019, Nr. 12, :e126675DOI (Open Access)
-
Expansion of Stem Cell-Like CD4⁺ Memory T Cells during Acute HIV-1 Infection Is Linked to Rapid Disease ProgressionIn: Journal of Virology , Jg. 93 2019, Nr. 14DOI (Open Access)
-
Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart DiseaseIn: The Journal of Infectious Diseases (JID) , Jg. 219 2019, Nr. 3, S. 497 – 508DOI (Open Access)
-
Sex differences in vaccine-induced humoral immunityIn: Seminars in Immunopathology , Jg. 41 2019, Nr. 2, S. 239 – 249DOI (Open Access)
-
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complementIn: Science Immunology , Jg. 3 2018, Nr. 26, S. eaat7796DOI (Open Access)
-
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeIn: JCI Insight , Jg. 3 2018, Nr. 10, e98420DOI (Open Access)
-
Exploiting glycan topography for computational design of Env glycoprotein antigenicityIn: PLoS Computational Biology , Jg. 14 2018, Nr. 4, S. e1006093DOI (Open Access)
-
Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease.In: PLoS Pathogens , Jg. 14 2018, Nr. 4, S. e1006973DOI (Open Access)
-
Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in HumansIn: Journal of Virology , Jg. 92 2018, Nr. 23, S. e01143 – 18DOI (Open Access)
-
Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressorsIn: AIDS , Jg. 32 2018, Nr. 4, S. 443 – 450DOI (Open Access)
-
Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccinationIn: Nature Communications , Jg. 9 2018, Nr. 1, S. 1212DOI (Open Access)
-
Differential inhibitory receptor expression on T cells delineates functional capacities in chronic viral infectionIn: Journal of Virology , Jg. 91 2017, Nr. 23, S. e01263 – 17DOI (Open Access)
-
Expression pattern of individual IFNA subtypes in chronic HIV infectionIn: Journal of Interferon & Cytokine Research , Jg. 37 2017, Nr. 12, S. 541 – 549
-
Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infectionIn: Scientific Reports , Jg. 7 2017, S. 7785DOI (Open Access)
-
Pre-exposure prophylaxis failure with tenofovir disoproxilIn: AIDS , Jg. 31 2017, Nr. 1, S. 176 – 177
-
Preexposure prophylaxis failure with tenofovir disoproxilIn: AIDS , Jg. 31 2017, Nr. 9, S. 1344
-
Preservation of peripheral T follicular helper cell function in HIV controllersIn: Journal of Virology , Jg. 91 2017, Nr. 14, S. e00497 – 17DOI (Open Access)
-
A Functional Role for Antibodies in TuberculosisIn: Cell , Jg. 167 2016, Nr. 2, S. 433 – 443.e14DOI (Open Access)
-
Antigen-Specific Antibody Glycosylation Is Regulated via VaccinationIn: PLoS Pathogens , Jg. 12 2016, Nr. 3, S. e1005456DOI (Open Access)
-
Antiviral CD8(+) T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal ExpansionIn: Immunity , Jg. 45 2016, Nr. 4, S. 917 – 930DOI (Open Access)
-
Barriers to HIV CureIn: HLA: Immune Response Genetics (Human Leukocyte Antigens) , Jg. 88 2016, Nr. 4, S. 155 – 163
-
CD137 agonist therapy can reprogram regulatory T cells into cytotoxic CD4+ T cells with antitumor activityIn: The Journal of Immunology (JI) , Jg. 196 2016, Nr. 1, S. 484 – 492DOI (Open Access)
-
Circulating HIV-Specific Interleukin-21In: Immunity , Jg. 44 2016, Nr. 1, S. 167 – 178DOI (Open Access)
-
Designing optimal HIV-vaccine T-cell responsesIn: Current Opinion in HIV and AIDS , Jg. 11 2016, Nr. 6, S. 593 – 600
-
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16In: Mucosal Immunology , Jg. 9 2016, Nr. 6, S. 1549 – 1558
-
Expansion of Inefficient HIV-Specific CD8 T Cells during Acute InfectionIn: Journal of Virology , Jg. 90 2016, Nr. 8, S. 4005 – 4016DOI (Open Access)
-
Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategiesIn: Mucosal Immunology , Jg. 9 2016, Nr. 6, S. 1584 – 1595DOI (Open Access)
-
Subdominant Gag-specific anti-HIV efficacy in an HLA-B*57-positive elite controllerIn: AIDS , Jg. 30 2016, Nr. 6, S. 972 – 974DOI (Open Access)
-
TGF-β receptor maintains CD4 T helper cell identity during chronic viral infectionsIn: The Journal of Clinical Investigation (JCI) , Jg. 126 2016, Nr. 10, S. 3799 – 3813
-
AIDS virus seeks refuge in B cell folliclesIn: Nature Medicine , Jg. 21 2015, Nr. 2, S. 111 – 112
-
Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV ViremiaIn: Journal of Virology , Jg. 89 2015, Nr. 15, S. 7494 – 7505DOI (Open Access)
-
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems SerologyIn: Cell , Jg. 163 2015, Nr. 4, S. 988 – 998DOI (Open Access)
-
HIV-specific TFH cells induced by vaccination and natural infectionIn: Journal of Medical Primatology , Jg. 44 2015, Nr. 5, Special Issue: 32nd Annual Symposium on Nonhuman Primate Models for AIDS, S. 321
-
IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infectionIn: Nature Communications , Jg. 6 2015, S. 7562DOI (Open Access)
-
Preparing for future European HIV prevention efficacy trials : lessons on willingness to participate and barriers to participation from ten German clinics serving behaviorally vulnerable men who have sex with men
18th European AIDS Conference (EACS 2021), Online & London, United Kingdom, October 27-30, 2021,In: HIV Medicine , Jg. 22 2021, Nr. S3, S. 244 – 245 -
A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically-suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-US-292-1824)In: Journal of the International AIDS Society , Jg. 21 2018, Nr. Suppl. 6, e25148DOI (Open Access)
-
HIV Impfstoff : Illusion oder bald Realität?
Die kleine Form, 27. April 2016, Essen,2016 (Die kleine Form 2016)